Trial 3C-13-1


A Phase III Double-blinded, Placebo Controlled Study of XilonixTM for Improving Survival in Metastatic Colorectal Cancer.

Type: Treatment
Phase: Phase III
Status: Not Open (Closed)
Treatments: Immunotherapy
Randomized: Yes
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Afsaneh Barzi, M.D.
Other Trial Staff:  Ramona Lujan, R.N., Yan Ning, D.M., Raluca Agafitei, Coordinator, Marile Garcia, Coordinator, Melissa Wallman, Coordinator, Noureddine Miloud, D.M., Yanli Wang, D.M., Rabia Rehman, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.